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ShdA is a large outer membrane protein of the autotransporter family whose passenger domain binds the
extracellular matrix proteins fibronectin and collagen I, possibly by mimicking the host ligand heparin. The
ShdA passenger domain consists of 1,500 amino acid residues that can be divided into two regions based on
features of the primary amino acid sequence: an N-terminal nonrepeat region followed by a repeat region
composed of two types of imperfect direct amino acid repeats, called type A and type B. The repeat region
bound bovine fibronectin with an affinity similar to that for the complete ShdA passenger domain, while the
nonrepeat region exhibited comparatively low fibronectin-binding activity. A number of fusion proteins con-
taining truncated fragments of the repeat region did not bind bovine fibronectin. However, binding of the
passenger domain to fibronectin was inhibited in the presence of immune serum raised to one truncated
fragment of the repeat region that contained repeats A2, B8, A3, and B9. Furthermore, a monoclonal antibody
that specifically recognized an epitope in a recombinant protein containing the A3 repeat inhibited binding of
ShdA to fibronectin.
Nontyphoidal Salmonella serotypes are the most frequent
cause of food-borne illness with a lethal outcome in the United
States (28). The serotype currently isolated most frequently
from human cases of nontyphoidal salmonellosis in the United
States is Salmonella enterica serotype Typhimurium (30). In-
fections commonly result from animal-to-human transmission,
primarily through food products derived from livestock or do-
mestic fowl (30). One of the main risk factors for introducing
Salmonella serotypes into the human food supply is their pres-
ence in the intestines of healthy food animals. In the United
States, between 1 and 6% of farm animals test positive for
intestinal carriage of Salmonella serotypes (6–11, 27, 37).
Stress during transport and long periods with intermittent
feeding increase the spread of Salmonella among livestock and
domestic fowl prior to slaughter (5, 7, 13, 18, 19, 27, 29, 31, 32).
As a result, Salmonella serotypes can on average be isolated
from 10% of apparently healthy animals prior to slaughter
(7, 27, 37). Intestinal carriage or chronic infection of mesen-
teric lymph nodes may result in contamination of equipment
surfaces or workers’ hands at processing plants, leading to
contamination of carcasses and processed foods (14, 29, 31,
32). These considerations indicate the prime importance of
intestinal carriage of Salmonella serotypes in healthy livestock
and domestic fowl for food safety in the United States. How-
ever, little is known about the mechanisms that allow Salmo-
nella serotypes to persist in the intestines of apparently healthy
animals. Elucidation of the underlying molecular mechanisms
of intestinal persistence is needed to devise intervention strat-
egies aimed at decreasing the prevalence of Salmonella sero-
types at the preharvest level. We have previously described the
identification of the ShdA outer surface protein of serotype
Typhimurium, the first salmonella-specific factor involved in
persistent intestinal carriage in the murine model of infection.
A serotype Typhimurium strain harboring a mutation in
shdA is shed with the feces at reduced numbers and for a
shorter period of time than its isogenic parent in a mouse
model of intestinal persistence (20, 23). The recovery of the
shdA mutant in reduced numbers from the feces of mice cor-
relates with its reduced ability to colonize the murine cecum,
the organ that serves as the main reservoir of luminal serotype
Typhimurium in this animal model (20). Immunohistochemical
analysis of cecal tissue from infected mice demonstrates that
serotype Typhimurium colonizes the cecal mucosa on the ep-
ithelial brush border and at areas of epithelial erosion where
the extracellular matrix is exposed to the intestinal lumen (22).
ShdA is a large outer membrane protein of serotype Typhi-
murium that binds the extracellular matrix protein fibronectin
(22). The carboxy-terminal region of ShdA (residues 1560 to
2036) shows homology with the C-terminal domains of outer
membrane proteins of the autotransporter family (16, 17), in-
cluding AIDA of diffuse adhering Escherichia coli (1, 2) and
IcsA (VirG) of Shigella flexneri (4, 12, 25). The C-terminal
domains of AIDA and IcsA are predicted to form beta barrels
in the outer membrane through which an N-terminal passenger
domain is transported to the bacterial surface (1, 34, 35).
However, the N-terminal passenger domains of AIDA and
IcsA show no sequence homology with ShdA. Flow cytometric
analysis demonstrates that the surface of serotype Typhi-
murium can be labeled with antiserum raised against the N-
* Corresponding author. Present address: The Wellcome Trust
Sanger Institute, The Wellcome Trust Genome Campus, Hinxton,
Cambridgeshire, CB10 1SA, United Kingdom. Phone: 44 (0)1223
495381. Fax: 44 (0)1223 494919. E-mail: rak@sanger.ac.uk.
4931
 o
n
 Septem
ber 21, 2018 by guest
http://jb.asm.org/
D
ow
nloaded from
 
terminal domain of ShdA (residues 59 to 1553), suggesting that
this part of the protein is surface localized (22). Expression of
ShdA in serotype Typhimurium increases binding of fibronec-
tin to the bacterial surface (22). The passenger domain of
ShdA binds in a heparin-sensitive mechanism to fibronectin at
the Hep-2 domain via interaction with at least one cationic
residue present on the surface of the 13FnIII repeat module
that is also the binding site for the anionic polysaccharide
heparin. ShdA also bound to a second heparin-binding protein,
collagen I, by a heparin-sensitive mechanism, suggesting that
ShdA binding activity may represent a form of molecular mim-
icry of heparin binding (21). Collectively, these data suggest
that ShdA-mediated binding of the extracellular matrix may be
a mechanism for persistent intestinal carriage of serotype Ty-
phimurium. To further study the molecular mechanism of
ShdA-mediated host-pathogen interaction, we investigated the
functional regions of the ShdA passenger domain and identi-
fied a region that contains the primary fibronectin-binding site.
MATERIALS AND METHODS
Construction and expression of recombinant proteins in E. coli. The expres-
sion and purification of a glutathione S-transferase (GST)-ShdA fusion protein
containing residues 59 to 1553 of ShdA (G-S59-1553) have been described previ-
ously (22). Plasmids for expression of GST fusion proteins with smaller segments
of ShdA (Fig. 1) were constructed by PCR amplification of the corresponding
regions in the shdA gene and subsequent cloning into the pGEX4T/1 vector
restriction enzymes EcoRI and SalI (Amersham Pharmacia). For expression of
fusion proteins, we used E. coli strain BL21 (Invitrogen). This strain, containing
the recombinant plasmids, was grown in Luria-Bertani broth supplemented with
100 mg of carbenicillin/liter to mid-log phase at 37°C with shaking, and expres-
sion was induced by the addition of IPTG (isopropyl--D-thiogalactopyranoside)
(Sigma, St. Louis, Mo.) to a final concentration of 1 mM. After incubation at
37°C with shaking for 4 h, the cells were harvested by centrifugation at 10,000 
g for 20 min. The pellet was resuspended in 15 ml of phosphate-buffered saline
(PBS), pH 7.4, and 5 ml of protease inhibitor cocktail (Sigma) was added. The
cells were lysed using a French pressure cell at 12,000 lb/in2, and the insoluble
fraction was separated by centrifugation. Fusion proteins were purified from the
soluble fraction by affinity chromatography using glutathione Sepharose (Amer-
sham Pharmacia) according to the manufacturer’s instructions. The fusion pro-
teins were eluted with 10 mM reduced glutathione (Sigma) in 50 mM Tris-HCl,
pH 8.5.
Solid-phase binding assay. Binding of GST-ShdA fusion proteins to fibronec-
tin-coated wells was determined using an enzyme-linked immunosorbent assay
(ELISA). Wells of a 96-well plate (Maxisorp; Nunc, Roskilde, Denmark) were
coated with 50 l of bovine fibronectin in 100 mM Tris-HCl, pH 8, per well for
12 h at 4°C at the concentrations indicated below. Additional binding sites were
blocked by incubation of 200 l of block buffer (2% [wt/vol] nonfat milk, 0.02%
[vol/vol] Tween 20 in PBS, pH 7.4) per well for 1 h. The block buffer was
removed, and the wells were washed three times with distilled H2O. The appro-
priate amount of test ligand in a volume of 50 l of PBS, pH 7.4, was added in
the presence or absence of inhibitor, and the plate was incubated for 90 min
at room temperature. The wells were washed three times with distilled H2O.
Bound ligand (G-S59–1553, G-S59–480, G-S480–581, G-S602–1048, G-S1086–1553, or
G-S470–1553) was detected using a 1/1,000 dilution of goat anti-GST antiserum
(Amersham Pharmacia) as the primary antibody and a 1/5,000 dilution of mono-
clonal anti-goat immunoglobulin G alkaline phosphatase conjugate as a second-
ary antibody. Alkaline phosphatase activity associated with each well was de-
tected by the addition of 1 mg of p-nitrophenyl phosphate/ml in 100 mM glycine,
2 mM MgCl2, and 1 mM ZnCl2. Alternatively, biotinylated protein ligand was
detected with 1/1,000 streptavidin-horseradish peroxidase polymer conjugate
(Sigma) in PBS, pH 7.4, and 0.04% Tween 20. The horseradish peroxidase
activity in each well was detected by the addition of 50 l of 0.4-mg/ml o-
phenylenediamine dihydrochloride- 0.4-mg/ml urea hydrogen peroxide in 50 mM
phosphate citrate buffer. Protein was biotinylated using sulfo-succinimidyl-6-
(biotinamido) hexanoate (Pierce, Rockford, Ill.) according to the manufacturer’s
instructions. Briefly, a 20-fold molar excess of sulfo-succinimidyl-6-(biotinamido)
hexanoate was incubated with a 1.5-mg/ml solution of G-S59–1553 or G-S470–1553
in PBS, pH 7.4, at room temperature for 30 min. The remaining unreacted
sulfo-succinimidyl-6-(biotinamido) hexanoate was removed by dialysis against 1
liter of PBS, pH 7.4, for 10 h at 4°C. The biotinylated protein was stored at
20°C for 1 month.
Production of immune serum. Antiserum was raised in 6-lb female New
Zealand White rabbits. A prebleed (5 ml) was taken, followed by the primary
immunization with a 1:1 mixture of fusion protein (0.5 mg) and Titer-Max Gold
(Sigma) adjuvant (total volume, 1 ml) injected subcutaneously at 10 different
locations. This procedure was repeated after 14 and 28 days. After a further 2
weeks, the rabbits were anesthetized with a Ketamine, Xylaxine, and Aceproma-
zine cocktail and exsanguinated by cardiac puncture. The serum was prepared by
standard methodology and preadsorbed with GST-glutathione Sepharose five
times.
MAb development. Production of monoclonal antibody (MAb) specific to
G-S470-1553 was performed essentially as described previously (3). For primary
screening of monoclonal hybridoma supernatants, ELISA plates were coated
overnight with 5 g of G-S470-1553 Tris-HCl (pH 8)/ml, and upon incubation of
the hybridoma supernatants, mouse anti-ShdA was detected with a peroxidase-
conjugated secondary antibody and H2O2-tetramethylbenzidine as the substrate
system. Immunopositive culture wells were then submitted to a secondary screen-
ing to test for the MAb’s capacity to block interaction of G-S470-1553 with fi-
bronectin. To this end, ELISA plates were coated with fibronectin (5 g of
Tris-HCl [pH 8]/ml). The plates were washed with distilled H2O and then
incubated with a mixture of the MAb and purified G-S470-1553. Binding of
G-S470-1553 to fibronectin-coated wells was detected with polyclonal rabbit anti-
ShdA (-ShdA) antiserum and a peroxidase-conjugated secondary antibody as
described above. The hybridomas that had lower photometric signals in this
secondary screening than in a control binding assay containing no MAb were
expanded, cloned by limiting dilution, and stored in liquid nitrogen for further
use. Two MAbs that produced the lowest photometric signals in the binding
assay were designated 3-9D 9F and 4-10A 11B, and a third that had no detectable
FIG. 1. Schematic representation of the ShdA primary sequence
and GST-ShdA fusion proteins used in this study. The full-length
ShdA protein is shown as an arrow, and GST fusion proteins are shown
as bars. The signal peptide and the C-terminal domain are predicted by
sequence homology with other members of the autotransporter family
(23). The passenger domain is composed of a nonrepeated region
(shaded bar) and a repeat region containing three type A repeats (A),
nine type B repeats (B), and intervening nonrepeated sequence (solid
bar).
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inhibitory activity was designated 4-10G 8G. For mass production of MAb 3-9D
9F, we used a membrane-based high-density cell culture technology (CELLine
1000; Integra Biosciences, Ijamsville, Md.).
RESULTS
Time dependence and affinity of ShdA binding to fibronec-
tin. Binding of the passenger domain of ShdA (G-S59-1553)
(Fig. 1) to fibronectin-coated wells was described previously
using ELISA (22). G-S59-1553 had a predicted molecular mass
of 178 kDa but migrated with an apparent molecular mass of
250 kDa in sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE). A discrepancy between the pre-
dicted molecular mass and the apparent molecular mass is
common for proteins containing acidic repeated sequences,
including FnbpA, a fibronectin-binding protein of Staphylococ-
cus aureus (26). The predicted passenger domain of ShdA is
also highly acidic, containing 188 (12%) acidic residues (glu-
tamate and aspartate) out of 1,498 total residues. To further
characterize fibronectin-binding activity, we first determined
the time dependency of binding using an ELISA. G-S59-1553
was added to 96-well plates coated with 1 nmol of bovine
fibronectin. After incubation for different time intervals,
the wells were washed, and the amount of well-associated
G-S59-1553 was detected with -GST antiserum using ELISA.
The amount of bound G-S59-1553 increased in a time-depen-
dent manner for the first 60 min. Incubation of fibronectin
and G-S59-1553 for 60 min did not increase the amount of
G-S59-1553 bound to wells, indicating that binding equilibrium
had been reached (data not shown). In all subsequent binding
assays, we therefore incubated test peptides in fibronectin-
coated wells for 60 min.
We next determined the concentration required for half-
maximal binding at equilibrium of G-S59-1553 to bovine plasma
fibronectin by using an ELISA. Increasing concentrations of
G-S59-1553 were added to 96-well plates coated with 0.25 g of
bovine plasma fibronectin and incubated for 60 min. The
amount of well-associated G-S59-1553 was detected with -GST
antiserum using ELISA (Fig. 2A). Saturation of binding was
reached at a G-S59-1553 concentration of 3  10
7 M, and
half-maximal binding occurred when the fusion protein was
added to wells at a concentration of 1.2  107 M.
The ShdA repeat region contains the primary fibronectin-
binding site. The ShdA passenger domain (residues 59 to
1553) of serotype Typhimurium consists of two regions, an
N-terminal region (residues 59 to 470; nonrepeat region) fol-
lowed by a second region (residues 470 to 1553; repeat region)
composed almost entirely of two types of imperfect and direct
amino acid repeats that we have designated repeat type A and
repeat type B (Fig. 1). The type A repeat consists of an 100-
amino-acid motif that is repeated three times. The type B
repeat consists of a 60-amino-acid motif that is repeated nine
times (23). To investigate whether either of these regions ex-
hibits binding in the absence of the other, we constructed
two GST fusion proteins consisting of residues 59 to 480
(G-S59-480) and 470 to 1553 (G-S470-1553) (Fig. 1). While
G-S59-480 migrates in SDS-PAGE at approximately its pre-
dicted molecular mass of 70 kDa, G-S470-1553 migrated at230
kDa, considerably higher than its predicted molecular mass of
136 kDa. This is likely due to the presence of acidic repeats in
this region. The fibronectin-binding properties of these fusion
proteins were compared by ELISA to those of GST and a
GST fusion containing the entire ShdA passenger domain
(G-S59-1553) (Fig. 3A). Binding of the nonrepeat region
(G-S59-480) to fibronectin-coated wells was greater than that of
GST but less than that of the entire ShdA passenger domain
(G-S59-1553). In contrast, the repeat region (G-S470-1553) bound
to immobilized fibronectin at a level comparable to that of the
ShdA passenger domain (G-S59-1553) under these conditions.
To determine the specificity of fibronectin binding by ShdA,
we tested the abilities of GST and GST fusion proteins con-
taining the nonrepeat region (G-S59–480) or the repeat region
(G-S470–1553) to inhibit binding of a biotinylated GST fusion
containing the ShdA passenger domain (biotin-G-S59–1553) to
bovine fibronectin in a solid-phase binding assay (Fig. 4A). A
biotinylated GST fusion to the ShdA passenger domain (bi-
otin-G-S59–1553) (33 nM) was incubated in 96-well plates
coated with bovine plasma fibronectin in the presence of in-
creasing concentrations (0.6, 6, 60, and 600 nM) of either GST,
G-S59–1553, G-S59–480, or G-S470–1553. The GST fusion protein
containing the ShdA passenger domain (G-S59–1553) inhibited
binding of biotin- G-S59–1553 to fibronectin at a concentration
FIG. 2. Binding kinetics of ShdA interaction with fibronectin. Bind-
ing of G-S59-1553 or G-S470-1553 to fibronectin (0.25 g)-coated 96-well
plates was determined by ELISA using -GST serum. G-S59-1553
(A) and G-S470-1553 (B) interactions with fibronectin were determined
by incubating increasing concentrations of ligand in fibronectin-coated
wells. After washes, the amount of well-associated GST fusion protein
was determined using -GST antibody in an ELISA. The mean optical
densities at 410 nm (OD410) from three identical wells 	 standard
errors are plotted.
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of 6 nM and inhibited binding by 50% at 60 nM. The GST
fusion protein containing the repeat region (G-S470–1553) in-
hibited binding at a concentration of 60 nM, and the GST
fusion containing the nonrepeat region (G-S59–480) exhibited
weak inhibition at a concentration of 600 nM (Fig. 4A). No
inhibitory activity of GST was detectable up to 600 nM.
To estimate the affinity of fibronectin binding to the ShdA
repeat region, we determined by ELISA the concentration
required for half-maximum binding at equilibrium for fi-
bronectin binding of G-S470-1553. Increasing concentrations of
the GST fusion protein containing the repeat region (G-S470-1553)
were added to 96-well plates coated with 5 g of bovine plasma
fibronectin/ml, and binding was allowed to proceed for 60 min
(Fig. 2B). The concentration of G-S470-1553 at which half-max-
imum binding to fibronectin was observed was 0.75  107
M. Thus, the ShdA passenger domain (Fig. 2A) and the ShdA
repeat region (Fig. 2B) bound fibronectin with similar affini-
ties. Together, these data suggested that the primary fibronec-
tin-binding domain was contained within the repeat region
(residues 470 to 1553) of the ShdA passenger domain.
Fibronectin-binding activity of truncated peptides derived
from the ShdA repeat region. To further investigate binding of
the ShdA repeat region, three additional GST-tagged fusion
proteins were constructed that together contained all of the
repeats present in the ShdA passenger domain. The first con-
tained repeat A1 (G-S480-581), the second contained repeats B1
through B7 (G-S602-1048), and the third contained repeats A2,
B8, A3, and B9 (G-S1086-1553) (Fig. 1). Both G-S602-1048 and
G-S1086-1553 migrated at apparent molecular masses greater
FIG. 3. Binding of ShdA passenger domain and truncated recom-
binant peptides. Thirty-three nanomolar G-S59-1553, G-S59-480, G-S470-1553,
or GST (A) and G-S59-480, G-S480-581, G-S602-1048, G-S1086-1553, or GST
(B) were incubated in wells coated with fibronectin (0.25 g). After
washes, the amount of well-associated GST fusion protein was deter-
mined using -GST antibody in an ELISA. The mean A410 values from
six identical wells 	 standard errors are plotted.
FIG. 4. Inhibition of biotin- G-S59–1553 or biotin- G-S470–1553 bind-
ing to fibronectin by unlabeled ShdA passenger domain or truncated
peptides. (A) Thirty-three nanomolar biotinylated G-S59–1553 was in-
cubated in wells coated with fibronectin (0.25 g) with increasing
amounts of G-S59–1553 (solid triangles), GST (solid squares), G-S59–480
(solid circles), or G-S470–1553 (open circles). (B) Thirty-three nanomo-
lar biotinylated G-S470–1553 was incubated in wells coated with fi-
bronectin (0.25 g) with increasing amounts of G-S480–581 (solid
triangles); G-S602–1048 (open squares); G-S1086–1553 (solid circles);
G-S470–1553 (open circles); a combination of G-S480–581, G-S602–1048,
and G-S1086–1553 (diamonds); or GST (solid squares). In each case,
biotin associated with each well following washing was determined by
ELISA using streptavidin conjugated with horseradish peroxidase. The
mean A410 values from six identical wells 	 standard errors, expressed
as percentages of values for control wells lacking added test peptides,
are plotted.
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than their predicted molecular masses of 71 and 76 kDa, re-
spectively, probably due to the presence of acidic repeats.
None of these fusion proteins (G-S480-581, G-S602-1048, or
G-S1086-1553) bound to fibronectin-coated wells at levels com-
parable to that of the entire repeat region (G-S470-1553) (Fig.
3B). While the GST fusion protein containing the A1 repeat
(G-S480-581) exhibited a small but significant increase in bind-
ing to fibronectin-coated wells compared to the GST control,
fusion proteins G-S602-1048 and G-S1086-1553 did not exhibit
greater binding than GST.
In order to address the question of whether the truncated
proteins were able to cooperate to bind bovine fibronectin, we
tested the ability of the A1 repeat (G-S480–581), the B1 to B7
repeats (G-S602–1048), and the A2, B8, A3, and B9 repeats
(G-S1086–1553) to inhibit the binding of a biotinylated GST
fusion containing the repeat region of the ShdA passenger
domain (biotin- G-S59–1553) to bovine fibronectin in a solid-
phase binding assay (Fig. 4B) individually and in combination.
The biotinylated GST fusion to the repeat region (biotin- G-
S470–1553) was incubated in 96-well plates coated with bovine
plasma in the presence of increasing concentrations of G-
S470–1553, G-S480–581, G-S602–1048, G-S1086–1553, or GST. The
GST fusion protein containing the complete repeat region
(G-S470–1553) inhibited binding of biotin- G-S470–1553 to fi-
bronectin at a concentration of 60 nM. The GST fusion pro-
teins G-S480–581, G-S602–1048, and G-S1086–1553 and GST, indi-
vidually or in combination, did not exhibit inhibitory activity
(Fig. 4B). This suggested that either the fibronectin-binding
sites within the repeat region overlap the truncated recombi-
nant proteins (G-S480–581, G-S602–1048, and G-S1086–1553) and
cannot function separately or the truncated proteins do not
fold correctly.
Inhibition of fibronectin binding by polyclonal immune se-
rum. A potential limitation of measuring the binding and/or
inhibitory activities of truncated peptides derived from the
ShdA passenger domain is that binding activity may be affected
as a result of misfolding. To overcome these potential limita-
tions, we determined the ability of rabbit immune sera specific
for the truncated peptides of ShdA to inhibit the binding of the
GST fusion protein containing the ShdA passenger domain
(G-S59–1553) to bovine fibronectin in a solid-phase binding as-
say. As a negative control, we constructed a GST fusion con-
taining a region of the C-terminal domain of ShdA (residues
1594 to 1860), a region thought to mediate transport of the
ShdA passenger domain across the bacterial outer membrane
(G-S1594–1860) (Fig. 1) but not fibronectin binding. Rabbit im-
mune sera were raised against the GST fusion proteins con-
taining the ShdA passenger domain (G-S59–1553), repeat A1
(G-S480–581), repeats B1 to B7 (G-S602–1048), the region con-
FIG. 5. Reactivities of rabbit immune sera raised against
G-S59-1553, G-S1594-1860, G-S480-581, G-S602-1048, G-S1086-1553, and naïve
serum. The top panel shows a 4 to 15% gradient SDS-PAGE stained
with Coomassie blue in which a total of 3 g of purified G-S59-1553,
G-S470-1553, G-S1594-1860, G-S480-581, G-S602-1048, G-S1086-1553 or GST/
lane was separated. The other panels are Western blots of a 4 to 15%
gradient polyacrylamide gel in which 0.15 g of the recombinant pro-
teins/lane was separated by SDS-PAGE. Western blots were detected
with antisera raised against each recombinant protein or naïve serum
(as indicate beside each panel) that was previously preadsorbed with
purified GST-glutathione Sepharose. The positions of the 250-, 100-,
50-, and 25-kDa molecular mass standards (top to bottom) are indi-
cated by horizontal bars on the left of each panel.
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taining repeats A2, B8, A3, and B9 (G-S1086–1553), and the
C-terminal domain (G-S1594–1860). To remove anti-GST anti-
bodies, each serum was preadsorbed with GST bound to glu-
tathione Sepharose resin. Following preadsorption, anti-GST
antibodies were not detectable with any of the sera by Western
blotting (Fig. 5). Antiserum raised against the ShdA passenger
domain (-G-S59–1553) detected GST fusion proteins contain-
ing all regions of the ShdA passenger domain but did not
detect the GST fusion protein raised against the C-terminal
domain (G-S1594–1860). Antiserum raised against the C-termi-
nal domain fragment (G-S1594–1860) detected only this protein.
Antisera raised against G-S480–581, G-S602–1048, and G-S1086–1553
each detected the passenger domain and the repeat region in
addition to the protein used to immunize in each case. The
abilities of these antisera to inhibit fibronectin binding by the
ShdA passenger domain (G-S59–1553) were determined by
ELISA (Fig. 6). In the presence of antiserum raised against the
ShdA passenger domain (-G-S59–1553), binding to fibronectin-
coated 96-well plates was reduced to
10% of that observed in
the presence of preimmune serum (Fig. 6). This indicated that
antibodies in the polyclonal serum that recognized one or
more epitopes of the ShdA passenger domain were able to
compete with fibronectin for binding to ShdA. To further lo-
calize the positions of these epitopes, we tested the abilities of
sera raised to the truncated peptides of the ShdA passenger
domain to inhibit binding of the ShdA passenger domain to
bovine fibronectin. Antisera raised against repeat A, repeats
B1 to B7, or the C-terminal domain (-G-S1594–1860) did not
significantly decrease binding of the ShdA passenger domain
(G-S59–1553) to bovine fibronectin. In contrast, the presence of
antiserum raised to repeats A2, B8, A3, and B9 reduced bind-
ing to 40% of that in the presence of preimmune serum,
suggesting that an important component of the ligand-binding
domain may be contained in this region.
Inhibition of fibronectin binding by ShdA-specific MAbs. A
second approach, complementary to that described in the pre-
vious section, was used to identify the region of ShdA that
contained the fibronectin-binding domain. MAbs specific to
ShdA were tested by ELISA for the ability to inhibit ShdA
interaction with fibronectin-coated wells. Hybridoma cells
were generated from suspensions of splenocytes from mice
hyperimmunized with a recombinant protein containing resi-
dues 470 to 1553 of ShdA by fusion with Sp2/0 myeloma cells.
Culture supernatants from 18 independent hybridoma cell
lines that secreted immunoglobulin G specific for G-S470-1553
varied in their abilities to inhibit ShdA binding to fibronectin-
coated wells in an ELISA (data not shown). Three MAbs,
designated 4-10A 11B, 3-9D 9F, and 4-10G 8G, were charac-
terized further. Coincubation of MAbs 4-10A 11B and 3-9D 9F
resulted in reduction of ShdA binding to fibronectin-coated
wells to 6 and 25%, respectively, of binding in the absence of
MAb. In contrast, coincubation of MAb 4-10G 8G did not
result in reduced binding of ShdA to fibronectin-coated wells
(Fig. 7). The locations of epitopes recognized by each MAb
were identified by expression of recombinant N-terminal GST
fusion proteins containing fragments of the ShdA repeat re-
gion in E. coli and subsequent separation by SDS-PAGE. Fol-
lowing Western transfer, the immobilized proteins were de-
tected with each MAb or -GST polyclonal serum (Fig. 8A).
4-10G 8G, which did not inhibit ShdA binding, recognized an
FIG. 6. Inhibition of ShdA binding to fibronectin by rabbit immune
sera raised to ShdA fragments. Shown is the binding of G-S59-1553 (33
nM) to wells coated with fibronectin (0.25 g) in the presence of rabbit
immune sera raised against the recombinant proteins G-S1594-1860,
G-S59-1553, G-S480-581, G-S602-1048, and G-S1086-1553. Each serum was
preadsorbed with GST prior to the assay. After washes, the amount of
well-associated S59-1553 fusion protein was determined using -GST
antibody in an ELISA. Binding is expressed as a percentage of binding
in the presence of naïve serum. The mean A410 values from four
identical wells 	 standards errors, expressed as percentages of values
for control wells lacking added test peptides, are plotted. Percentages
were converted logarithmically before the calculation of statistics.
FIG. 7. Inhibitory activities of MAbs on ShdA binding to fibronec-
tin. Shown is binding of G-S59-1553 (33 nM) to wells coated with fi-
bronectin (0.25 g) in the presence of MAbs 4-10G 8G, 4-10A 11B,
and 3-9D 9F. After washes, the amount of well-associated S59-1553
fusion protein was determined using -GST antibody in an ELISA.
Binding is expressed as a percentage of binding in the absence of MAb.
The mean A410 values from four identical wells 	 standard errors,
expressed as percentages of values for control wells lacking added test
peptides, are plotted. SN, supernatant.
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epitope in the recombinant protein containing repeats B1 to
B7 and one containing repeats A2, B8, A3, and B9 but not one
containing repeat A1. In contrast, 4-10A 11B and 3-9D 9F
recognized an epitope present in the recombinant protein con-
taining repeats A2, B8, A3, and B9 but not that present in
repeat A1 or repeats B1 to B7 (Fig. 8A). Further analysis with
recombinant proteins containing smaller fragments from the
region containing repeats A2, B8, A3, and B9 indicated that
4-10A 11B and 3-9D 9F recognize distinct epitopes (Fig. 8B).
4-10A 11B recognized an epitope in the recombinant protein
containing repeats A2, B8, and A3, but smaller fragments,
including ones with overlapping sequence, were not recog-
nized. In contrast, 3-9D 9F recognized all recombinant pro-
teins containing repeat A3. Repeat A3 is a 97-residue sequence
containing 16 acidic residues.
DISCUSSION
The mechanisms by which Salmonella serotypes persist in
the intestines of livestock and domestic fowl is a matter of
considerable relevance to food safety and public health. The
outer surface protein ShdA, an autotransporter family protein
of serotype Typhimurium, is essential for long-term persistent
intestinal carriage in a murine model of salmonellosis. Many
FIG. 8. Epitope mapping of MAbs. Whole-cell lysates of E. coli expressing the GST fusion proteins G-S470-1553, G-S480-581, G-S602-1048, and
G-S1086-1553 (A) or G-S1086-1553, G-S1086-1417, G-S1086-1186, G-S1187-1318, G-S1215-1278, G-S1319-1417, G-S1086-1278, G-S1215-1417, and G-S1319-1503 (B) were
separated on 4 to 15% gradient SDS-PAGE, transferred to membranes by Western blotting, and detected with polyclonal -GST immune serum
or MAb as indicated below each panel. Positive signals are indicated by arrows.
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autotransporter family proteins that are essential for the viru-
lence of a number of gram-negative bacteria are known to
interact with host proteins via their extracellular localized pas-
senger domain. This suggested to us that ShdA may also in-
teract with host proteins and that this property may be involved
in persistent intestinal carriage. We previously reported that
ShdA binds extracellular matrix proteins, including fibronectin
and collagen I, but it is unknown whether these binding prop-
erties are required for ShdA-mediated persistent intestinal car-
riage. Abrogation of ShdA interaction with fibronectin during
natural infections and observation of the effect of this on per-
sistent intestinal carriage is necessary to test the hypothesis
that fibronectin-binding activity, or binding activity to other
receptors mediated by the same ligand-binding domain of
ShdA, is necessary for ShdA-mediated persistent intestinal car-
riage. As a first essential step toward addressing this question,
we have investigated ShdA interaction with fibronectin in vitro
to define domains containing the primary binding sites.
Here, we have investigated ShdA binding to fibronectin by a
number of approaches that implicated the repeat region of the
passenger domain as containing the primary ligand-binding
domain. In a first approach, the repeat region of the ShdA
passenger domain was implicated in fibronectin binding, since
a recombinant protein containing the repeat region, but not
one containing the N-terminal nonrepeat region, bound to
fibronectin with similar affinity as measured by the concentra-
tion of ligand required to achieve half-maximal binding at
equilibrium (100 nM in each case). These data were sup-
ported by the observation that the repeat region, but not the
nonrepeat region, was able to inhibit binding of the passenger
domain to fibronectin. It was not possible to calculate the
dissociation constant for the ShdA interaction with fibronectin.
However, it is important to note that the reported concentra-
tion at which half-maximal binding at equilibrium was ob-
served is likely an underestimate, since the recombinant fusion
proteins used in this study were prone to degradation during
expression in the E. coli host. This degradation could not be
reduced by expression in protease-negative strains (data not
shown). Since we found that the truncated peptides of the
repeat region did not retain binding activity, it is likely that
only the full-length protein contributed to binding in the assays
reported here (21, 38).
The repeat region has an estimated molecular mass of 100
kDa and consists of 1,073 residues, the majority of which are
components of either type A or type B repeated sequence
modules. Since smaller recombinant proteins containing frag-
ments of the repeat region did not retain the ability to bind
fibronectin, it seems unlikely that fibronectin binds a simple
linear sequence within ShdA. Rather, it is likely that a rela-
tively large region of ShdA, when folded correctly, is required
for the ligand-binding domain to adopt the appropriate con-
formation. A similar situation has been described for the in-
vasin protein of Yersinia pseudotuberculosis, whose binding to
1 integrins requires a minimal region consisting of 192 resi-
dues of a C-terminal domain for molecular mimicry of fi-
bronectin binding of 1 integrins (24). However, the absence
or incorrect folding of neighboring domains had no measur-
able effect on ligand binding of recombinant invasin using in
vitro binding assays. Invasin molecular mimicry of fibronectin
1 integrin binding is dependent on three key residues that
have identical separations in both fibronectin and invasin. The
crystal structure model of invasin demonstrates that the three
key residues of invasin (Asp811, Asp911, and Arg863), which
are distantly separated on the primary amino acid sequence,
are present in different protruding loops on the carboxyl-ter-
minal domain (15). The precise conformation of the loops, and
therefore the key residues, is heavily dependent on correct
folding of the domain. The repeat region of ShdA may also
form a single domain that when correctly folded has one or
more binding sites for fibronectin.
Our second approach to study ShdA binding to fibronectin
involved the use of ShdA-specific polyclonal antibodies or
MAbs. The fact that only polyclonal serum raised against ei-
ther the entire ShdA passenger domain or a recombinant pro-
tein containing A2, B8, A3, and B9 was capable of inhibiting
ShdA binding to fibronectin was the first indication that the
repeats A2, B8, A3, and B9 contained important components
of the ligand-binding domain. Furthermore, of three ShdA-
specific MAbs, the epitopes recognized by the two MAbs that
inhibited ShdA binding (3-9D 9F and 4-10A 11B) were
mapped to the A2-B8-A3 repeats, while the MAb (4-10G 8G)
with no inhibitory activity was mapped to an epitope present in
the B1 to B7 repeats. That 4-10A 11B was unable to recognize
overlapping recombinant proteins smaller than A2-B8-A3 sug-
gested that this MAb recognized an epitope not present in
these truncated peptides, presumably due to misfolding. How-
ever, 3-9D 9F recognized all recombinant proteins containing
the A3 repeat, suggesting that the sequence in this part of the
correctly folded ShdA repeat region contributes an exposed
surface, binding to which inhibits interaction with fibronectin
either by directly competing for a binding site or by steric
hindrance. ShdA binds one or more basic amino acids that
form a cationic cradle in the Hep-2 domain of fibronectin via
electrostatic forces (21). It therefore seems likely that acidic
residues in the ShdA ligand-binding domain are involved in
this interaction. The A3 repeat is composed of 97 residues, of
which 16 have acidic side chains (aspartate or glutamate).
Since the cationic cradle of the fibronectin Hep-2 domain
forms a continuous patch of positive charge contributed from
six surface-exposed basic residues, it seems likely that several
acidic residues from repeat A3, and potentially other residues
from elsewhere in the ShdA passenger domain, may contribute
to binding.
That the repeat region alone is necessary and sufficient for
maximal fibronectin binding in vitro raises a question as to the
function of the nonrepeat region. The nonrepeat region con-
sists of 421 residues with a predicted molecular mass of 42 kDa
that contain no common sequence motifs and exhibit no amino
acid homology with sequences in the available databases. It is
possible that the nonrepeat region has a second activity unre-
lated to that of the fibronectin domain of the repeat region. A
multidomain and multifunctional character has been described
for a number of bacterial outer surface proteins. For example,
the FnbpA protein of S. aureus has multiple fibronectin-bind-
ing motifs in an extended carboxy domain and fibrinogen-
binding activity in a globular domain in the N-terminal domain
(33, 36). These binding activities are completely independent,
since fragments containing only one domain retain maximal
binding activity for its cognate receptor (26). Another possi-
bility is that the nonrepeat region of ShdA, while not directly
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participating in fibronectin binding in vitro, may nonetheless
be required for either secretion or correct presentation of the
ligand-binding domain (repeat region) on the bacterial cell
surface and thus may be required to facilitate interaction with
fibronectin or other ligands during natural infections.
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